The Drugs controller General of India (DCGI), on Sunday, announced approval of two vaccines Oxford-AstraZeneca's Covishield manufactured by Serum Institute of India and Bharat Biotech's Covaxin against coronavirus infection
The Health Department conducted the survey from September 3-16 to estimate corona prevalence in those aged 18 and above in 30 districts across the southern state.